Need for performance protocols in tee and tcd for detection of right to left shunts

Journal of Neuroimaging

Volumn 24, Issue 2, 2014, Pages 144-148

  Chang, Jason J ^a   Darbonne, Carol ^a   Drumm, Denise A ^b   Teleb, Mohamed S ^c   Frey, James L ^a  

^a BARROW NEUROLOGICAL INSTITUTE   (United States)

^b ClinMetrics Inc   (United States)

^c Stanford Medicine Children s Health   (United States)

Author keywords

Paradoxical stroke; Patent foramen ovale; Stroke; Transcranial doppler; Transesophageal echocardiogram; Transthoracic echocardiogram

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOLOGIST; CEREBROVASCULAR ACCIDENT; CLINICAL PROTOCOL; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; ECHOCARDIOGRAPH; FEMALE; HEART RIGHT LEFT SHUNT; HUMAN; IMAGE ANALYSIS; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MICROBUBBLE; MIDDLE AGED; NEUROLOGIST; OPERATOR; RADIOLOGIST; RETROSPECTIVE STUDY; SENSITIVITY ANALYSIS; TRANSCRANIAL DOPPLER; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSIENT ISCHEMIC ATTACK; ADOLESCENT; COMPLICATION; DOPPLER ECHOGRAPHY; ECHOGRAPHY; EVALUATION STUDY; ISCHEMIC ATTACK, TRANSIENT; NEEDS ASSESSMENT; OBSERVER VARIATION; PATENT FORAMEN OVALE; PRACTICE GUIDELINE; PROCEDURES; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; STANDARDS; UNITED STATES; VALIDATION STUDY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; FEMALE; FORAMEN OVALE, PATENT; HUMANS; ISCHEMIC ATTACK, TRANSIENT; MALE; MIDDLE AGED; NEEDS ASSESSMENT; OBSERVER VARIATION; PRACTICE GUIDELINES AS TOPIC; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; ULTRASONOGRAPHY, DOPPLER, TRANSCRANIAL; UNITED STATES; YOUNG ADULT;

EID: 84896720603     PISSN: 10512284     EISSN: 15526569     Source Type: Journal    
DOI: 10.1111/j.1552-6569.2012.00729.x     Document Type: Article

References (30)

1. Kerut EK, Norfleet WT, Plotnick GD, et al. Patent foramen ovale: a review of associated conditions and the impact of physiological size. J Am Coll Cardiol 2001;38:613-623.
2. Hagen PT, Scholz DG, Edwards WD. Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts. Mayo Clin Proc 1984;59:17-20.
3. Penther P. Patent foramen ovale: an anatomical study. Apropos of 500 consecutive autopsies. Arch Mal Coeur Vaiss 1994;87:15-21.
4. Souteyrand G, Motreff P, Lusson JR, et al. Comparison of transthoracic echocardiography using second harmonic imaging, transcranial Doppler, and transesophageal echocardiography for the detection of patent foramen ovale in stroke patients. Eur J Echocardiogr 2006;7:147-154.
5. Chen WJ, Lin SL, Cheng JJ, et al. The frequency of patent foramen ovale in patients with ischemic stroke: a transesophageal echocardiographic study. J Formos Med Assoc 1991;90:744-748.
6. Hausmann D, Mugge A, Becht I, et al. Diagnosis of patent foramen ovale by transesophageal echocardiography and association with cerebral and peripheral embolic events. Am J Cardiol 1992;70:668-672.
7. Mas JL, Arquizan C, Lamy C, et al. Patent Foramen Ovale and Atrial Septal Aneurysm Study Group. Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N Engl J Med 2001;345(24):1740-1746.
8. Ueno Y, Shimada Y, Tanaka R, et al. Patent foramen ovale with atrial septal aneurysm may contribute to white matter lesions in stroke patients. Cerebrovasc Dis 2010;30:15-22.
9. Di Tullio M, Sacco RL, Venketasubramanian N, et al. Comparison of diagnostic techniques for the detection of a patent foramen ovale in stroke patients. Stroke 1993;24:1020-1024.
10. Cramer SC, Rordorf G, Maki JH, et al. Increased pelvic vein thrombi in cryptogenic stroke: results of the Paradoxical Emboli from Large Veins in Ischemic Stroke (PELVIS) study. Stroke 2004;35(1):46-50.
11. Belkin RN, Pollack BD, Ruggiero ML, et al. Comparison of transesophageal and transthoracic echocardiography with contrast and color flow Doppler in the detection of patent foramen ovale. Am Heart J 1994;128:520-525.
12. Heckmann JG, Niedermeier W, Brandt-Pholmann M, et al. Detection of patent foramen ovale. Transesophageal echocardiography and transcranial Doppler sonography with ultrasound contrast media are "supplementary, not competing, diagnostic methods." Med Klin 1999;94:367-370.
13. Klotzsch C, Janssen G, Berlit P. Transesophageal echocardiography and contrast-TCD in the detection of a patent foramen ovale: experiences with 111 patients. Neurology 1994;44:1603-1606.
14. Kobayashi K, Iguchi Y, Kimura K, et al. Contrast transcranial Doppler can diagnose large patent foramen ovale. Cerbrovasc Dis 2009;27:230-234.
15. Ozdemir AO, Tamayo A, Munoz C, et al. Cryptogenic Stroke and patent foramen ovale: clinical clues to paradoxical embolism. J Neurol Sci 2008;275:121-127.
16. Devuyst G, Despland PA, Bogousslavsky J, et al. Complementarity of contrast transcranial Doppler and contrast transesophageal echocardiography for the detection of patent foramen ovale in stroke patients. Eur Neurol 1997;38:21-25.
17. Droste DW, Kriete JU, Stypmann J, et al. Contrast transcranial Doppler ultrasound in the detection of right-to-left shunts: comparison of different procedures and different contrast agents. Stroke 1999;30:1827-1832.
18. Mangiafico S, Scandura S, Ussia GP, et al. Transesophageal echocardiography and transcranial color Doppler: independent or complementary diagnostic tests for cardiologists in the detection of patent foramen ovale? J Cardiovasc Med 2009;10:143-148.
19. Jauss M, Zanette E. Detection of Right-to-Left Shunt with Ultrasound Contrast Agent and Transcranial Doppler Sonography. Cerbrovasc Dis 2000;10:490-496.
20. Schwarze JJ, Sander D, Kukla C, et al. Methodological parameters influence the detection of right-to-left shunts by contrast transcranial Doppler ultrasonography. Stroke 1999;30:1234-1239.
21. Lao AY, Sharma VK, Tsivgoulis G, et al. Effect of body positioning during transcranial Doppler detection of right-to-left shunts. Eur J Neurol 2007;14:1035-1039.
22. Droste DW, Schmidt-Rimpler C, Wichter T, et al. Right-to-left shunts detected by transesophageal echocardiography and transcranial Doppler sonography. Cerebrovasc Dis 2004;17:191-196.
23. Zanette EM, Mancini G, De Castro S, et al. Patent foramen ovale and transcranial Doppler: comparison of different procedures. Stroke 1996;27:2251-2255.
24. Droste DW, Silling K, Stypmann J, et al. Contrast transcranial Doppler ultrasound in the detection of right-to-left shunts: time window and threshold in microbubble numbers. Stroke 2000;31:1640-1645.
25. Droste DW, Jekentaite R, Stypmann J, et al. Contrast transcranial Doppler ultrasound in the detection of right-to-left shunts: comparison of Echovist-200 and Echovist-300, timing of the Valsalva maneuver, and general recommendations for the performance of the test. Cerebrovasc Dis 2002;13:235-241.
26. Furlan AJ, Reisman M, Massaro J, et al. CLOSURE I Investigators. Study design of CLOSURE I: A prospective, multicenter, randomized controlled trial to evaluate the safety and efficacy of the STARFlex® Septal Closure System versus best medical therapy in patients with a stroke or transient ischemic attack due to presumed paradoxical embolism through a patent foramen ovale. Stroke 2010;41:2872-2883.
27. Serena J, Marti-Fa'bregas J, Santamarina E, et al. On behalf of CODICIA (Right-to-Left Shunt in Cryptogenic Stroke) Study; for the Stroke Project of the Cerebrovascular Diseases Study Group, Spanish Society of Neurology. Recurrent stroke and massive right-to-left shunt. Results from the Prospective Spanish Multicenter (CODICIA) Study. Stroke 2008;39:3131-3136.
28. Kutty S, Brown K, Qureshi AM, et al. Maximal potential patent foramen diameter does not correlate with the type or frequency of the neurologic event prior to closure. Cardiology 2009;113:111-115.
29. Jesurum JT, Fuller CJ, Moehring MA, et al. Unilateral versus bilateral middle cerebral artery detection of right-to-left shunt by power M-mode transcranial Doppler. J Neuroimaging 2009;19:235-241.
30. Prospective, Randomized Investigation to Evaluate Incidence of Headache Reduction in Subjects with Migraine and PFO Using the AMPLATZER PFO Occluder to Medical Management. ClinicalTrials.gov Identifier: NCT00355056